Investment strategy

Our focus is early-stage Life Science companies. We are looking for:

  • Nordic company within Life Science
  • Professional loyal organization seeking smart capital and additional expertise
  • Clearly defined need (for product or service)
  • Scalable
  • Patent/certification ready or imminent
  • Possible exit < 5 år
  • Clear business model
  • Strong innovation level
  • Paying customers
    (alternatively testing customers)
  • B2B
  • Valuation of companies < 100 mSEK
  • Desired capital 3-20 mSEK in actual financing round
  • Possibility of follow-on investments in successful portfolio companies

Life Science invest has an investment committee that evaluates potential companies for investment in a structured manner. What we mainly look at in this phase is:

N
Need for the service/product
N
The solution, i.e. customer benefit
N
Market and potential (market knowledge, Go-to-market strategy, etc.)
N
Uniqueness - competitors, positioning IP/Patents/technology
N
Business model - sales cycle, price, partners/distributors, etc.
N
Organization / Team - competence supply
N
The offer - clarity
N
The valuation
N
Action plan - is the plan realistic with the capital sought?
N
Exit - plans/strategies
N
Overall assessment - proceed or not